Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Tirzepatide is a prescription medication that functions as both a GIP and GLP-1 receptor agonist
Before you take this drug, be sure to talk with your doctor about your health history
The company recently reported that its closely watched next-gen obesity shot CagriSema failed to top Lilly's dual GLP-1/GIP agonist Zepbound in a direct comparison study
Compounded semaglutide from licensed 503A pharmacies offers flexibility in dosing, lower pricing, and access regardless of insurance status or prior authorization barriers
Obesity-associated improvements in metabolic profile through expansion of adipose tissue
As of May 31, 2026 the agency had documented 990 reports for compounded semaglutide and more than 730 for compounded tirzepatide, while noting that federal law does not require state-licensed pharmacies that are not outsourcing facilities to submit adverse events, so those figures understate the real total
US$ 27.04
US$ 28.57
:max_bytes(150000):strip_icc()/not-eating-signs-symptoms-5201896_final-c41f6a10844343059195cfb13e561098.jpg)
US$ 20.68
